The Discounted Cash Flow (DCF) valuation of China Pioneer Pharma Holdings Ltd (1345.HK) is 2.57 HKD. With the latest stock price at 2.10 HKD, the upside of China Pioneer Pharma Holdings Ltd based on DCF is 22.3%.
Based on the latest price of 2.10 HKD and our DCF valuation, China Pioneer Pharma Holdings Ltd (1345.HK) is a buy. buying 1345.HK stocks now will result in a potential gain of 22.3%.
| Range | Selected | |
| WACC / Discount Rate | 5.7% - 8.5% | 7.1% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 1.86 - 4.52 | 2.57 |
| Upside | -11.5% - 115.3% | 22.3% |